Envoy Medical Statistics

Total Valuation

Envoy Medical has a market cap or net worth of $35.64 million. The enterprise value is $54.36 million.

Market Cap	35.64M
Enterprise Value	54.36M

Important Dates

The next estimated earnings date is Friday, May 23, 2025, after market close.

Earnings Date	May 23, 2025
Ex-Dividend Date	n/a

Share Statistics

Envoy Medical has 21.33 million shares outstanding. The number of shares has increased by 35.09% in one year.

Current Share Class	21.33M
Shares Outstanding	21.33M
Shares Change (YoY)	+35.09%
Shares Change (QoQ)	+30.48%
Owned by Insiders (%)	37.83%
Owned by Institutions (%)	14.13%
Float	10.73M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	153.51
Forward PS	143.61
PB Ratio	-1.47
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	256.42
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.09

Current Ratio	1.09
Quick Ratio	0.71
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-15.28

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-129.07%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-698.17%
Revenue Per Employee	$5,048
Profits Per Employee	-$632,714
Employee Count	42
Asset Turnover	0.02
Inventory Turnover	0.52

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.61% in the last 52 weeks. The beta is 2.32, so Envoy Medical's price volatility has been higher than the market average.

Beta (5Y)	2.32
52-Week Price Change	-47.61%
50-Day Moving Average	1.40
200-Day Moving Average	2.05
Relative Strength Index (RSI)	69.08
Average Volume (20 Days)	16,696

Short Selling Information

The latest short interest is 84,842, so 0.40% of the outstanding shares have been sold short.

Short Interest	84,842
Short Previous Month	95,964
Short % of Shares Out	0.40%
Short % of Float	0.79%
Short Ratio (days to cover)	6.85

Income Statement

In the last 12 months, Envoy Medical had revenue of $212,000 and -$26.57 million in losses. Loss per share was -$1.36.

Revenue	212,000
Gross Profit	-603,000
Operating Income	-19.48M
Pretax Income	-23.04M
Net Income	-26.57M
EBITDA	-19.28M
EBIT	-19.48M
Loss Per Share	-$1.36

Full Income Statement

Balance Sheet

The company has $5.31 million in cash and $24.03 million in debt, giving a net cash position of -$18.72 million or -$0.88 per share.

Cash & Cash Equivalents	5.31M
Total Debt	24.03M
Net Cash	-18.72M
Net Cash Per Share	-$0.88
Equity (Book Value)	-24.22M
Book Value Per Share	-1.14
Working Capital	717,000

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$16.09 million and capital expenditures -$877,000, giving a free cash flow of -$16.96 million.

Operating Cash Flow	-16.09M
Capital Expenditures	-877,000
Free Cash Flow	-16.96M
FCF Per Share	-$0.80

Full Cash Flow Statement

Margins

Gross Margin	-284.43%
Operating Margin	-9,188.21%
Pretax Margin	-9,208.96%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Envoy Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-35.09%
Shareholder Yield	-35.09%
Earnings Yield	-74.56%
FCF Yield	-47.59%

Analyst Forecast

The average price target for Envoy Medical is $9.13, which is 446.28% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.13
Price Target Difference	446.28%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Envoy Medical has an Altman Z-Score of -44.43 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-44.43
Piotroski F-Score	1